Lv1
8 积分 2026-05-28 加入
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
12小时前
已完结
Optimal timing of anti-PD-1 antibody combined with chemotherapy administration in patients with NSCLC
14小时前
已完结
Lenvatinib combined with PD-1 inhibitor plus Gemox chemotherapy versus plus HAIC for advanced biliary tract cancer
15小时前
已完结
Hepatic arterial infusion of GEMOX plus systemic gemcitabine chemotherapy combined with lenvatinib and PD-1 inhibitor in large unresectable intrahepatic cholangiocarcinoma
15小时前
求助中
Trastuzumab Rezetecan in Human Epidermal Growth Factor Receptor 2–Expressing Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer: A Multicenter, Open-Label, Phase I Trial
1个月前
已完结
Immune checkpoint inhibitors with trastuzumab and chemotherapy in advanced HER2-positive gastric cancer: A systematic review and meta-analysis
1个月前
已完结
Recent Progress in Treatment for HER2-Positive Advanced Gastric Cancer
1个月前
已完结
Development of treatment strategies for advanced HER2-positive gastric cancer: Insights from clinical trials
1个月前
已完结
皖公网安备34019202002308
